Materials & Innovations
Next Generation
Capabilities
Our research pipeline embodies a innovation-driven, multidisciplinary strategy aimed at exploring and exploiting the versatility of collagen – one of nature’s most abundant structural proteins – for a broad range of biomedical, biotechnological, and advanced material applications.
The approach reflects a deep commitment to scientific creativity, translational research, and sustainable innovation through strategic collaborations with universities, research centers, and clinical partners.
The pipeline is structured along
four complementary innovation axes:
New generation collagen production and characterization
Recombinant collagen production from Saccharomyces cerevisiae and collagen extraction from marine sources (Tilapia, Orata), including studies on how fish age and diet affect collagen quality.
Advanced characterization of collagen structure-property relationships, including the effects of processing and enzymatic residues.
These efforts aim to create high-quality, traceable, and sustainable collagen sources, fostering circular economy principles and reducing reliance on animal sources.
Biofabrication & 3D tissue engineering
Development of collagen-based bioinks and hydrogels for 3D bioprinting and in vitro tissue models, including:
- Intestinal models
- Muscular dystrophy models
- Skin models
- Neural and cardiac differentiation platforms
- Spheroid culture systems
This axis leverages cutting-edge biofabrication technologies to create biomimetic environments, accelerating both basic research and drug testing while paving the way for personalized regenerative therapies.
Innovative collagen-based
medical devices and regenerative solutions
Design and development of implantable collagen devices such as:
- Bi-layered scaffolds for urinary tract regeneration
- Ultra-resistant collagen implants for bone reconstruction
- Porous membranes for wound healing and bone regeneration
- Anti-adhesive coatings for gastrointestinal stents
- Collagen coatings to enhance dental implant osseointegration
Creation of injectable formulations enriched with platelet extracts for aesthetic medicine and nano-collagen formulations for advanced dermatological applications.
Controlled-release microparticles for delivering anti-inflammatory agents or growth factors.
These innovations combine collagen’s inherent bioactivity with functional materials engineering, targeting unmet clinical needs with safe and bioresorbable solutions.
Hybrid collagen-based
smart materials and devices
Development of collagen-nanoparticle composites for antibacterial wound dressings and light-responsive materials.
Exploration of collagen matrices as conductors in emerging electrochromic devices, opening new avenues in bioelectronics and wearable devices.
This axis reflects the spirit of cross-sectoral innovation, positioning collagen not only as a biomedical material but as a platform for next-gen smart and responsive systems.
Innovation Spirit behind the strategy
At its core, this pipeline demonstrates:
A strong innovation culture grounded in cross-disciplinary collaboration (biotech, materials science, clinical research, bioelectronics).
A focus on sustainability and bio-inspired innovation by valorizing marine byproducts and using recombinant technologies.
An open mind to unconventional applications, exploring collagen’s role in emerging fields like bioelectronics and smart coatings.
An integrated value chain approach: from collagen sourcing and production → to advanced characterization → to application-driven development.
A commitment to translational impact, with projects designed to move from bench to bedside, addressing real-world medical challenges.